STAT3 and neoplasm: The constitutive activation of STAT3 can be controlled by various mechanisms, including the loss of negative regulators (PTPs, SOCS, and PIAS), the formation of positive feedback mechanisms in the tumor microenvironment, elevated activity of upstream kinases, and somatic mutations in the STAT3 gene [63].